A promoter polymorphism of the Fc receptor-like 3 gene, FCRL3, and a SNP within the RUNX1 binding site of SLC22A4 have also been implicated in RA susceptibility [17]–[19], both with conflicting reports [20],[21]. This evidence concerns the gene FCRL3 and rheumatoid arthritis.